Drug Shortage Report for RANITIDINE INJECTION USP

Last updated on 2019-09-10 History
Report ID 93458
Drug Identification Number 02256711
Brand name RANITIDINE INJECTION USP
Common or Proper name RANITIDINE
Company Name SANDOZ CANADA INCORPORATED
Active Ingredient(s) RANITIDINE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 50ml
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-08-19
Estimated end date 2019-09-30
Actual end date
Shortage status Actual shortage
Updated date 2019-09-10
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-09-10 French Compare
v1 2019-09-10 English Compare